GSK, a prominent British pharmaceutical company, has announced its acquisition of biopharmaceutical company Aiolos Bio for a staggering $1.4 billion. This strategic move allows GSK to bolster its respiratory pipeline and aligns with the recent trend of pharmaceutical giants acquiring rapidly growing biotechs to strengthen their portfolios. Aiolos Bio, headquartered in both San … [Read more...] about GSK Expands Respiratory Pipeline with Acquisition of Aiolos Bio
Footer
